• 2023

    Buzzetti R, Minicucci L, Cirilli N, Raia V, Salvatore D, Daniele A. Medicina delle evidenze - DAL CYSTIC FIBROSIS DATABASE (CFDB): STATO NUTRIZIONALE NON ADEGUATO, COSA FARE?. Orizzonti FC, 2023;20 (2):35-38

    Leggi

    • 2023

    Cresta F, Buzzetti R, Bertolo S. Conoscere ed interpretare le differenze – THE EFFECT OF INHALED HYPERTONIC SALINE ON LUNG STRUCTURE IN CHILDREN AGED 3-6 YEARS WITH CYSTIC FIBROSIS (SHIP-CT): A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL. Orizzonti FC, 2023;20 (2):28-32

    Leggi

    • 2023

    Cresta F, Buzzetti R, Braggion C. Conoscere ed interpretare le differenze – EMBEDDED SPECIALIST PALLIATIVE CARE IN CYSTIC FIBROSIS: RESULTS OF RANDOMIZED FEASIBILITY CLINICAL TRIAL. Orizzonti FC, 2023;20 (2):32-34

    Leggi

    • 2023

    Lucca F, Buzzetti R, Braggion C. Conoscere ed interpretare le differenze – EFFECT OF AIRWAY CLEARANCE THERAPIES ON MUCOCILIARY CLEARANCE IN ADULTS WITH CYSTIC FIBROSIS: A RANDOMIZED CONTROLLED TRIAL. Orizzonti FC, 2023;20 (3):31-34

    Leggi

    • 2023

    Lucca F, Buzzetti R, Di Leonardo A. Conoscere ed interpretare le differenze – INHALED MRNA THERAPY FOR TREATMENT OF CYSTIC FIBROSIS: INTERIM RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1/2 CLINICAL STUDY. Orizzonti FC, 2023;20 (3):27-31

    Leggi

    • 2023

    Majo F, Buzzetti R, Minicucci L. Conoscere ed interpretare le differenze – Commenti ad articoli della letteratura. THE EFFECT OF AZITHROMYCIN ON STRUCTURAL LUNG DISEASE IN INFANTS WITH CYSTIC FIBROSIS (COMBACT CF): A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED CLINICAL TRIAL. Orizzonti FC, 2023;20 (1):28-30

    Leggi

    • 2023

    Majo F, Buzzetti R, Mori G, Percudani R. Conoscere ed interpretare le differenze – DISCONTINUATION VERSUS CONTINUATION OF HYPERTONIC SALINE OR DORNASE ALFA IN MODULATOR TREATED PEOPLE WITH CYSTIC FIBROSIS (SIMPLIFY): RESULTS FROM TWO PARALLEL, MULTICENTRE, OPENLABEL, RANDOMIZED, CONTROLLED, NON-INFERIORITY TRIALS. Orizzonti FC, 2023;20 (1):24-28

    Leggi

    • 2023

    R. Buzzetti, L. Minicucci, N. Cirilli, V. Raia, D. Salvatore, A. Daniele. Dal Cystic Fibrosis DataBase (CFDB): È utile la terapia antinfiammatoria con Azitromicina?. Orizzonti FC, 2023;20 (1):31-33

    Leggi

    • 2022

    Ardissino G, Vergori A, Vergori C, Martelli L,Daccò V, Villa MC, Masciani M, Monzani A, Salice P, Ghiglia S, Perrone M, Capone V, Mancuso MC, Giussani A, Pieri GR, Bosco A, Brambilla M, Romano R, Rotondo S, Buzzetti R. Multiple, random spot urine sampling for estimating urinary sodium excretion. Eur J Pediatr, 2022;181(1):83-90

    Leggi

    • 2022

    Lagolio E, Demurtas J, Buzzetti R, Cortassa G, Bottone S, Spadafora L, Cocino C, Smith L, Benzing T, Polidori MC . A rapid and feasible tool for clinical decision making in community-dwelling patients with COVID-19 and those admitted to emergency departments: the Braden-LDH-HorowITZ Assessment-BLITZ. Intern Emerg Med, 2022;17(3):839-844

    Leggi